HCSGD entry for IFNG
1. General information
Official gene symbol | IFNG |
---|---|
Entrez ID | 3458 |
Gene full name | interferon, gamma |
Other gene symbols | IFG IFI |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in PPI subnetwork.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000060 | Protein import into nucleus, translocation | IDA | biological_process |
GO:0000122 | Negative regulation of transcription from RNA polymerase II promoter | ISS | biological_process |
GO:0001781 | Neutrophil apoptotic process | IEA | biological_process |
GO:0002026 | Regulation of the force of heart contraction | IEA | biological_process |
GO:0002053 | Positive regulation of mesenchymal cell proliferation | ISS | biological_process |
GO:0002250 | Adaptive immune response | IEA | biological_process |
GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response | IEA | biological_process |
GO:0003340 | Negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | ISS | biological_process |
GO:0005125 | Cytokine activity | IEA | molecular_function |
GO:0005133 | Interferon-gamma receptor binding | IEA | molecular_function |
GO:0005576 | Extracellular region | IDA TAS | cellular_component |
GO:0005615 | Extracellular space | IEA | cellular_component |
GO:0006915 | Apoptotic process | IGI | biological_process |
GO:0006928 | Cellular component movement | TAS | biological_process |
GO:0006959 | Humoral immune response | IEA | biological_process |
GO:0007050 | Cell cycle arrest | IDA | biological_process |
GO:0007166 | Cell surface receptor signaling pathway | TAS | biological_process |
GO:0009615 | Response to virus | IDA | biological_process |
GO:0009897 | External side of plasma membrane | IEA | cellular_component |
GO:0019221 | Cytokine-mediated signaling pathway | TAS | biological_process |
GO:0019882 | Antigen processing and presentation | IEA | biological_process |
GO:0030593 | Neutrophil chemotaxis | IEA | biological_process |
GO:0030968 | Endoplasmic reticulum unfolded protein response | IEA | biological_process |
GO:0031642 | Negative regulation of myelination | IEA | biological_process |
GO:0032224 | Positive regulation of synaptic transmission, cholinergic | IEA | biological_process |
GO:0032700 | Negative regulation of interleukin-17 production | IDA | biological_process |
GO:0032735 | Positive regulation of interleukin-12 production | IDA | biological_process |
GO:0032747 | Positive regulation of interleukin-23 production | IDA | biological_process |
GO:0032760 | Positive regulation of tumor necrosis factor production | IEA | biological_process |
GO:0033141 | Positive regulation of peptidyl-serine phosphorylation of STAT protein | IDA NAS | biological_process |
GO:0034393 | Positive regulation of smooth muscle cell apoptotic process | IDA | biological_process |
GO:0042102 | Positive regulation of T cell proliferation | IEA | biological_process |
GO:0042493 | Response to drug | IEA | biological_process |
GO:0042511 | Positive regulation of tyrosine phosphorylation of Stat1 protein | IDA | biological_process |
GO:0042742 | Defense response to bacterium | IEA | biological_process |
GO:0042832 | Defense response to protozoan | IEA | biological_process |
GO:0044130 | Negative regulation of growth of symbiont in host | IEA | biological_process |
GO:0045080 | Positive regulation of chemokine biosynthetic process | IEA | biological_process |
GO:0045084 | Positive regulation of interleukin-12 biosynthetic process | IEA | biological_process |
GO:0045348 | Positive regulation of MHC class II biosynthetic process | IEA | biological_process |
GO:0045410 | Positive regulation of interleukin-6 biosynthetic process | IEA | biological_process |
GO:0045429 | Positive regulation of nitric oxide biosynthetic process | IDA | biological_process |
GO:0045666 | Positive regulation of neuron differentiation | IEA | biological_process |
GO:0045672 | Positive regulation of osteoclast differentiation | IDA | biological_process |
GO:0045785 | Positive regulation of cell adhesion | IEA | biological_process |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | IEA | biological_process |
GO:0048304 | Positive regulation of isotype switching to IgG isotypes | IEA | biological_process |
GO:0048662 | Negative regulation of smooth muscle cell proliferation | IDA | biological_process |
GO:0050718 | Positive regulation of interleukin-1 beta secretion | IEA | biological_process |
GO:0050796 | Regulation of insulin secretion | IDA | biological_process |
GO:0051044 | Positive regulation of membrane protein ectodomain proteolysis | IDA | biological_process |
GO:0051607 | Defense response to virus | IEA | biological_process |
GO:0051712 | Positive regulation of killing of cells of other organism | IDA | biological_process |
GO:0060333 | Interferon-gamma-mediated signaling pathway | TAS | biological_process |
GO:0060334 | Regulation of interferon-gamma-mediated signaling pathway | TAS | biological_process |
GO:0060550 | Positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity | IDA | biological_process |
GO:0060552 | Positive regulation of fructose 1,6-bisphosphate metabolic process | IDA | biological_process |
GO:0060557 | Positive regulation of vitamin D biosynthetic process | IDA | biological_process |
GO:0060559 | Positive regulation of calcidiol 1-monooxygenase activity | IDA | biological_process |
GO:0071222 | Cellular response to lipopolysaccharide | IEA | biological_process |
GO:0071351 | Cellular response to interleukin-18 | IEA | biological_process |
GO:0072308 | Negative regulation of metanephric nephron tubule epithelial cell differentiation | ISS | biological_process |
GO:0097191 | Extrinsic apoptotic signaling pathway | IDA | biological_process |
GO:2000309 | Positive regulation of tumor necrosis factor (ligand) superfamily member 11 production | IDA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.5907815243 | 0.8615385168 | 0.9999902473 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.0030504673 |
GSE13712_SHEAR | Down | -0.0137904376 |
GSE13712_STATIC | Down | -0.0545452400 |
GSE19018 | Up | 0.1957471772 |
GSE19899_A1 | Up | 0.1387856168 |
GSE19899_A2 | Down | -0.1222068486 |
PubMed_21979375_A1 | Down | -0.1221754007 |
PubMed_21979375_A2 | Up | 0.1315956083 |
GSE35957 | Up | 0.2015139452 |
GSE36640 | Up | 0.0917672323 |
GSE54402 | Up | 0.0718213961 |
GSE9593 | Up | 0.0387847530 |
GSE43922 | Up | 0.0191952488 |
GSE24585 | Down | -0.0004313336 |
GSE37065 | Down | -0.0079895288 |
GSE28863_A1 | Down | -0.0526527110 |
GSE28863_A2 | Down | -0.0886107063 |
GSE28863_A3 | Up | 0.1252205643 |
GSE28863_A4 | Up | 0.0960698491 |
GSE48662 | Up | 0.0150412912 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
Olsalazine | DB01250 | - |
Glucosamine | DB01296 | EXPT01563 |
VIR201 | DB05110 | - |
Fontolizumab | DB05111 | - |
Apremilast | DB05676 | - |
- MicroRNAs
- mirTarBase
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-16-5p | MIMAT0000069 | MIRT006912 | Luciferase reporter assay//qRT-PCR | Functional MTI | 22379033 |
hsa-miR-15a-5p | MIMAT0000068 | MIRT006913 | Luciferase reporter assay//qRT-PCR | Functional MTI | 22379033 |
hsa-miR-15b-5p | MIMAT0000417 | MIRT006914 | Luciferase reporter assay//qRT-PCR | Functional MTI | 22379033 |
hsa-miR-29b-3p | MIMAT0000100 | MIRT007034 | Luciferase reporter assay | Functional MTI | 22772450 |
hsa-miR-409-3p | MIMAT0001639 | MIRT007285 | Luciferase reporter assay | Functional MTI | 23360331 |
hsa-miR-26b-5p | MIMAT0000083 | MIRT029122 | Microarray | Functional MTI (Weak) | 19088304 |
Entries Per Page
Displaying Page of
- mirRecord
No target information from mirRecord
- mirRecord
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 29 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
27173733 | IFN-gamma(-/-) NOD |
27057461 | As a part of cellular pathogen defense, IFNgamma triggers induction of NADPH oxidase NOX2, which produces superoxide into phagosomes of immune cells |
27057461 | IFNgamma is capable of inducing expression of constitutively active NADPH oxidase NOX4 in tumor cells leading to generation of reactive oxygen species (ROS) damaging DNA, activation of DNA damage response and cell cycle arrest/premature cellular senescence |
27039820 | We here aimed to investigate cellular senescence in immortalized cholangiocyte and cholangiocarcinoma cell lines using five different inducing agents: 5-aza-2'deoxycytidine, bromodeoxyuridine, interferons (IFNbeta and IFNgamma), and hydrogen peroxide |
26857736 | Human CCR7(low)CD45RA(high) effector memory CD8(+) T cells (terminally differentiated TEMRA) are reportedly a functionally compromised population with characteristics of cellular senescence when examined ex vivo Although their frequencies are increased in elderly subjects in association with declined immune competence, however, it remains unclear whether their impaired functions can be reversed so that they contribute to immune responses in vivo Here, I show that, in contrast to TCR stimulation, stimulation of TEMRA with IL-15 induced a unique transcriptional signature, promoted IFN-gamma production and cell cycle entry, and reduced chemotaxis toward sphingosine-1-phosphate (S1P) |
26802028 | XAF1 induction with interferon-gamma (IFN-gamma) treatment was abrogated by BRD7 knockdown, which resulted in blocking interferon-induced senescence |
26802028 | In lung cancer cells, XAF1 tumor suppressor activity was decreased by BRD7 knockdown, and inhibition of tumor growth by IFN-gamma did not appear in BRD7-depleted xenograft tumors |
25982278 | IFNgamma induces oxidative stress, DNA damage and tumor cell senescence via TGFbeta/SMAD signaling-dependent induction of Nox4 and suppression of ANT2 |
25982278 | While cytokines such as tumor necrosis factor-alpha (TNFalpha) and interferon gamma (IFNgamma) are important components of senescence-associated secretome and induce senescence in, for example, mouse pancreatic beta-cancer cell model, their downstream signaling pathway(s) and links with oxidative stress and DDR are mechanistically unclear |
25982278 | Using human and mouse normal and cancer cell models, we now show that TNFalpha and IFNgamma induce NADPH oxidases Nox4 and Nox1, reactive oxygen species (ROS), DDR signaling and premature senescence |
25982278 | Unlike mouse tumor cells that required concomitant presence of IFNgamma and TNFalpha, short exposure to IFNgamma alone was sufficient to induce Nox4, Nox1 and DDR in human cells |
25982278 | Furthermore, the expression of adenine nucleotide translocase 2 (ANT2) was suppressed by IFNgamma contributing to elevation of ROS and DNA damage |
25090227 | Among the anti-inflammatory cytokines, the production of prostaglandin E2 (PGE2) and the expression of its primary enzyme, cyclooxygenase-2 (COX-2), were profoundly increased by pre-stimulation with interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha), and this response was significantly decreased with consecutive passages |
25083993 | Despite their apparent senescent state, we determined that these cells secreted high levels of both TNF-alpha and IFN-gamma and showed potent cytotoxic activity |
24913980 | Finally, in accordance with much evidence indicating that DDR and oxidative stress are major determinants of cellular senescence, we found that redox-dependent DDR activation upon chemotherapeutic treatment is critical for MM cell entry in premature senescence and is required for the preferential ligand upregulation on senescent cells, which are preferentially killed by NK cells and trigger potent IFN-gamma production |
24175851 | IFN-gamma plays an indirect anti-cancer role through the immune system but may have direct negative effects on cancer cells |
24175851 | We exposed AGS, HGC-27 and GES-1 gastric cancer cell lines to IFN-gamma and found significantly reduced colony formation ability |
24175851 | Flow cytometry revealed no effect of IFN-gamma on apoptosis of cell lines and no effect on cell aging as assessed by beta-gal staining |
24175851 | Microarray assay revealed that IFN-gamma changed the mRNA expression of genes related to the cell cycle and cell proliferation and migration, as well as chemokines and chemokine receptors, and immunity-related genes |
24175851 | Finally, flow cytometry revealed that IFN-gamma arrested the cells in the G1/S phase |
24175851 | IFN-gamma may slow proliferation of some gastric cancer cells by affecting the cell cycle to play a negative role in the development of gastric cancer |
22182806 | Memory T-cells were assessed by interferon (IFN)-gamma ELISpot assay and flow cytometrically via IFN-gamma or IL-2 |
22182806 | Proportions of CD57(bright)CD28(null) CD4+ T-cells correlated with IFN-gamma responses to CMV (p =0 |
22182806 | Proportions of CD57(bright)CD28(null) CD8+T-cells and CD8+ T-cell IFN-gamma responses to CMV peptides correlated in controls but not HIV patients |
22182806 | IL-2 was predominantly produced by CD28+T-cells from all donors, whereas IFN-gamma was mostly produced by CD57+ T-cells |
22182806 | The findings provide evidence of an accumulation of immunosenescent T-cells able to make IFN-gamma |
21764762 | Coculture of wild-type p53-induced human tumor cells with primary human NK cells enhanced NKG2D-dependent degranulation and IFN-gamma production by NK cells |
21635686 | Moreover, pretreatment of CD4+CD28(null) T cells with IL-15 displayed a synergistic effect on the IFN-gamma production in CMV-specific responses, which was not observed in CD4+CD28+ T cells |
20100671 | No impairment in IFN-gamma production by CD57+ T cells from the genital tract was observed |
19885868 | Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence |
19885868 | Expression of the human HIN-200 family member IFI 16 has been reported to suppress cell growth and contribute to the onset of cellular senescence |
19885868 | Moreover, IFI 16 and hTERT co-localised within the nucleus and these two proteins physically interacted in vivo and in vitro |
19885868 | Together, these data suggest that IFI 16 may act as an endogenous regulator of telomerase activity and, through its interaction with hTERT, contributes to the inhibition of proliferation and induces a senescence-like state |
19802007 | JAK1/STAT-activating ligands, interleukin 10 (IL10), IL20, IL24, interferon gamma (IFNgamma), IFNbeta and IL6, were also expressed by senescent cells, supporting autocrine/paracrine activation of JAK1/STAT |
19493573 | We show here that pre-treatment of trophoblast cells and certain cancer cells with agents that activate stress pathways (Ras oncogene, PMA or H2O2) and induce senescence can substantially enhance the induction of immune response genes (MHC class II, CD40, MICA, MICB) by HDACi and restore a vigorous IFN-gamma response in trophoblast cells and tumor cells |
19133932 | The measurements of the alloimmune response-infiltrate, cytology, expression of perforin, granzyme B, IFN-gamma and MHC-were not increased in old allografts |
19071156 | IFN-gamma treatment increased ROS production, and an antioxidant, N-acetylcysteine, inhibited IFN-gamma-induced cellular senescence |
19071156 | Therefore, these results suggest that IFN-gamma might play an important role in cellular senescence through a p53-dependent DNA damage pathway and contribute to the pathogenesis of atherosclerosis via its pro-senescent activity |
17416406 | Although CD57 expression on blood and BAL cells was associated with a reduced proliferative potential, examination of beryllium-specific CD4(+) T cells in blood and lung revealed no difference in CD57 expression on cells that produced IFN-gamma only versus IFN-gamma and IL-2 |
16821141 | In inflamed portal tracts of PBC, CD4+ T cells of Th1 type expressing IFN-gamma or CXCR3 are aggregated and more commonly detected around injured bile ducts than Th2-type CD4+ T cells expressing IL-4 or CCR4, indicating that Th1-dominant cellular immunity plays a more-prominent role in recruitment of memory T-cell subsets in PBC and may be responsible for the progressive bile duct damage |
16806194 | However, the induction of immunosubunits by interferon-gamma (IFN-gamma) was lost in senescent cells |
16806194 | In contrast, levels of the 11S proteasome regulator, PA28, were increased by IFN-gamma even in senescent cells, and both immunosubunits and PA28 increased with the reversible growth arrest in confluent cell cultures |
16204645 | In CD8+ T cells and NK cells, the transcription factors T-bet and eomesodermin (Eomes) regulate maturation and effector functions, including IFN-gamma production |
16204645 | As Eomes null mice are not viable, real-time polymerase chain reaction comparisons between C57Bl/6J (B6) and alymphoid (Rag2(0/0)gammac0/0) mice were used to assess uNK cell expression of T-bet, Eomes, and the target genes IFN-gamma, granzyme A, and perforin |
16204645 | In uNK cells, transcripts for T-bet, Eomes, and IFN-gamma were most abundant in mature stage cells, and transcripts for granzyme A and perforin were lower at this stage than in immature or senescent cells |
15208661 | Role of IFI 16 in cellular senescence of human fibroblasts |
15208661 | Here we report that loss of IFN-inducible IFI 16 expression in human fibroblasts allows bypass of cellular senescence |
15208661 | We found that levels of IFI 16 mRNA and protein were higher in human old versus young fibroblasts and immortalization of fibroblasts with telomerase resulted in decreased expression of IFI 16 |
15208661 | Moreover, overexpression of IFI 16 in immortalized fibroblasts strongly inhibited cell proliferation |
15208661 | Interestingly, knockdown of IFI 16 expression in fibroblasts inhibited p53-mediated transcription, downregulated p21(WAF1) expression, and extended the proliferation potential |
15208661 | Importantly, treatment of immortal cell lines with 5-aza-2'-deoxycytidine, an inhibitor of DNA methyltransferase, resulted in upregulation of IFI 16 |
15208661 | Our observations support the idea that increased levels of IFI 16 in older populations of human fibroblasts contribute to cellular senescence |
12894224 | Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence |
12894224 | Here we report that IFI 16, an interferon-inducible transcriptional modulator from the p200-protein family, contributes to cellular senescence of prostate epithelial cells |
12894224 | Normal human prostate epithelial cells (PrEC) in culture expressed detectable levels of IFI 16, and the levels increased more than fourfold when cells approached cellular senescence |
12894224 | Consistent with a role of IFI 16 in cellular senescence, human prostate cancer cell lines either did not express IFI 16 or expressed a variant form, which was primarily detected in the cytoplasm of prostate cancer cells and not in the nucleus |
12894224 | Moreover, overexpression of functional IFI 16 in human prostate cancer cell lines inhibited colony formation |
12894224 | Additionally, ectopic expression of IFI 16 in clonal prostate cancer cell lines was associated with a senescence-like phenotype, production of senescence-associated beta-galactosidase (a biochemical marker for cellular senescence), and reduction of S-phase cells in culture |
12894224 | Importantly, upregulation of p21WAF1 and inhibition of E2F-stimulated transcription accompanied inhibition of cell growth by IFI 16 in prostate cancer cell lines |
12894224 | Collectively, our observations support the idea that increased levels of IFI 16 in PrECs contribute to senescence-associated irreversible cell growth arrest |
11872952 | In situ activated intestinal T cells expanded in vitro--without addition of antigen--produce IFN-gamma and IL-10 and preserve their function during growth |
11872952 | OBJECTIVE: The balance between mucosal CD4+ T cells producing IFN-gamma or IL-10 is essential in the maintenance of intestinal homeostasis |
11872952 | We aimed to investigate how in situ activated T cells were expanded in vitro according to a new cell culture protocol and if it selected for continuous clonal CD4+ T cells capable of producing mainly IFN-gamma or IL-10 |
11872952 | RESULTS: Cytokine production was increased in cultures from patients with Crohn's disease compared to controls (IFN-gamma, p = 0 |
7561522 | Rat and mouse fibroblasts were also found to produce nitric oxide when primed with IFN-gamma and simultaneously treated with IL-1, TNF-alpha, or LPS |
7561522 | The doses of IFN-gamma effective in priming fibroblasts for nitric oxide production were as low as 1-10 U/ml |
7561522 | Fibroblasts were also found to be distinct from macrophages in their sensitivity to the suppressive effects of transforming growth factor-beta, which in fibroblasts inhibited both IFN-gamma plus LPS- and IFN-gamma plus TNF-alpha-induced nitric oxide production |
7561522 | At the stage of growth crisis, a dramatic increase in nitric oxide production was observed in rat fibroblasts in response to IFN-gamma or TNF-alpha that may be directly correlated with cellular senescence |
8125178 | Most of these cells were treated with 200 to 1000 U recombinant bovine interferon-gamma (IFN-gamma) for 3 days |
8125178 | Growth rate: In the absence of IFN-gamma, the growth rate was high for cell types 3 and 4, moderate for cell type 1, and low for cell types 2 and 5 |
8125178 | The presence of IFN-gamma caused anti-proliferative effects |
8125178 | IFN-gamma could be cytotoxic on cell type 3 |
8513512 | Transfected T cells of both young and elderly subjects appear to display normal T cell function: they cease doubling upon removal of IL-2; in the presence of autologous adherent mononuclear cells they respond to mitogen stimulation and produce IL-2 and IFN-gamma during proliferation; and they express both IL-2 and transferrin receptors similar to those observed in mitogen-stimulated nontransfected T cells |
Entries Per Page
Displaying Page of